"Risperidone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
| Descriptor ID |
D018967
|
| MeSH Number(s) |
D03.383.742.698.685
|
| Concept/Terms |
R-64,766- R-64,766
- R 64,766
- R64,766
- R-64766
- R 64766
- R64766
|
Below are MeSH descriptors whose meaning is more general than "Risperidone".
Below are MeSH descriptors whose meaning is more specific than "Risperidone".
This graph shows the total number of publications written about "Risperidone" by people in this website by year, and whether "Risperidone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1998 | 2 | 0 | 2 |
| 1999 | 2 | 0 | 2 |
| 2002 | 1 | 0 | 1 |
| 2003 | 3 | 2 | 5 |
| 2004 | 1 | 0 | 1 |
| 2005 | 2 | 0 | 2 |
| 2006 | 3 | 0 | 3 |
| 2007 | 3 | 1 | 4 |
| 2008 | 3 | 0 | 3 |
| 2009 | 1 | 0 | 1 |
| 2012 | 2 | 1 | 3 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 2 | 1 | 3 |
| 2016 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Risperidone" by people in Profiles.
-
Pharmacotherapy of Autism Spectrum Disorder: Results from the Randomized BAART Clinical Trial. Pharmacotherapy. 2019 06; 39(6):626-635.
-
Prediction of Relapse After Discontinuation of Antipsychotic Treatment in Alzheimer's Disease: The Role of Hallucinations. Am J Psychiatry. 2017 04 01; 174(4):362-369.
-
Long-acting injectable vs oral risperidone for schizophrenia and co-occurring alcohol use disorder: a randomized trial. J Clin Psychiatry. 2015 Oct; 76(10):1359-65.
-
Relationship of Cognition to Clinical Response in First-Episode Schizophrenia Spectrum Disorders. Schizophr Bull. 2015 Nov; 41(6):1237-47.
-
A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes. Schizophr Bull. 2015 Nov; 41(6):1227-36.
-
Role of atypical antipsychotics in the treatment of generalized anxiety disorder. CNS Drugs. 2014 Jun; 28(6):519-33.
-
Alcohol-induced psychotic disorder in a 42-year-old female patient. JAAPA. 2013 Feb; 26(2):30, 32, 36.
-
A comparison of the PANSS pentagonal and Van Der Gaag 5-factor models for assessing change over time. Psychiatry Res. 2013 May 15; 207(1-2):134-9.
-
Relapse risk after discontinuation of risperidone in Alzheimer's disease. N Engl J Med. 2012 Oct 18; 367(16):1497-507.
-
The antipsychotic discontinuation in Alzheimer disease trial: clinical rationale and study design. Am J Geriatr Psychiatry. 2012 Apr; 20(4):362-73.